This list is an analysis based on recent market events. It's not an investment recommendation.
About
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.
Show more...
CEO
Mr. Fredericus A. Colen
Employees
49
Country
CA
ISIN
CA64065J4037
WKN
000A3DHGY
Listings
0 Comments
Share your thoughts
FAQ
What is Neovasc stock price today?▼
The current price of NVCN.TO is C$40.15 CAD — it has increased by +0.58% in the past 24 hours. Watch Neovasc stock price performance more closely on the chart.
What is Neovasc stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Neovasc stocks are traded under the ticker NVCN.TO.
What is Neovasc revenue for the last year?▼
Neovasc revenue for the last year amounts to 5.86M CAD.
What is Neovasc net income for the last year?▼
NVCN.TO net income for the last year is -59.99M CAD.
How many employees does Neovasc have?▼
As of April 01, 2026, the company has 49 employees.